Liposomes are lipids suspended in water with spherical self-enclosed systems, which have bilayer structures and an inner aqueous phase. 1) They have been used as models for biological membranes. Recently, liposomes have proven to be advantageous as carriers for drug delivery systems (DDS).
2)These advantages are biocompatibility, the ability to encapsulate both water-soluble and lipid-soluble molecules or even macromolecules, biodegradability and the ability to delivery drugs to the desired target tissues. However, liposomes are rapidly removed from the circulation following their intravenous administration, primarily by Kupffer cells in the liver and fixed macrophages in the spleen. Thus, it is important to develop modified liposomes that are able to avoid uptake by the reticuloendothelial system (RES) and extend their circulation half-life in vivo. Allen et al. 3,4) and Gabizon et al. 5) reported that the use of ganglioside G M1 as a lipid component of the liposomes allowed them to avoid or delay uptake by RES. More recently, many researchers have reported that liposomes (PEG-liposomes) conjugated with amphipathic polyethylene glycol (PEG) significantly increase the blood circulation liposome half-life compared to those without PEG.6-9) Furthermore, the actitivity of PEG-lipid was larger than that of ganglioside G M1 . The increased circulation halflife of PEG-liposomes has been attributed to the steric repulsive barrier due to the covalently attached PEG around the liposomes. 10,11) We have reported, [12][13][14] the effect of PEG-lipid on the physicochemical properties of liposomes. The addition of PEG-lipid to liposomes caused lateral phase separation, and the fluidity in the interfacial region of the liposomal bilayer membranes was markedly increased. In addition, the permeability of PEG-liposomes rapidly increased near the main phase transition temperature. Furthermore, the permeability of liposomes in the blood circulation is of the great interest when they are applied as drug carriers, especially for chemotherapy and gene therapy. It has been reported that many serum components interact with the liposomal bilayer membranes, in some cases causing them to release their entrapped materials more rapidly. [15][16][17] In this study, we investigated the effect of fetal bovine serum on the carboxyfluorescein leakage from PEG-liposomes.
ExperimentalMaterials L-a -Dipalmitoylphosphatidylcholine (DPPC, 99.6% pure) was obtained from NOF Co., Ltd., and distearoyl-N-monomethoxy poly-(ethylene glycol)-succinyl-phosphatidylethanolamines (DSPE-PEG) were acquired from NOF Co., Ltd. (Tokyo, Japan). The weight-average molecular weights of poly(ethylene glycol) were 1000, 2000, 3000 and 5000. 5-(6)-Carboxyfluorescein (CF, 99% pure) was purchased from Molecular Probes, Inc. (OR, U.S.A.) and was used without further purification. Fetal bovine serum (FBS) was purchased from Sanko Junyaku Co. Ltd. (Tokyo, Japan). Dulbecco's phosphate-buffered saline (PBS) powder, composed of NaCl, KCl, Na 2 HPO 4 and KH 2 PO 4 was purchased...